Maintenance of Multivitamin Supplements After Sleeve Gastrectomy

Hospital General Universitario Elche

Status and phase

Completed

Phase 3

Conditions

Iron Deficiency Anemia

Treatments

Drug: Multicentrum® (Pfizer, Spain) 12 months

Drug: Multicentrum® (Pfizer, Spain) 3 months

Study type

Interventional

Funder types

Other

Identifiers

NCT02620137

HURJC15-15

Details and patient eligibility

About

A prospective randomized study of patients undergoing a laparoscopic sleeve gastrectomy was performed. Patients were randomized into 2 groups: those patients receiving the multivitamin supplement during 3 months (Group 1), and those receiving the supplement during 12 months (Group 2). Laboratory data were recorded: vitamins and oligoelements at 3, 6 and 12 months after surgery.

Full description

A prospective randomized study of patients undergoing a laparoscopic sleeve gastrectomy was performed. Patients were randomized into 2 groups: those patients receiving the multivitamin supplement (Multicentrum, Pfizer, 1 tablet/day) during 3 months (Group 1), and those receiving the supplement during 12 months (Group 2). Laboratory data were recorded: vitamins (D, B12 and folic acid) and oligoelements (calcium, iron, phosphorus, magnesium and zinc) at 3, 6 and 12 months after surgery.

Enrollment

80 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

patients undergoing laparoscopic sleeve gastrectomy
BMI >40 Kg/m2
BMI > 35 Kg/m2 with the presence of comorbidities associated to obesity

Exclusion criteria

documented gastroesophageal reflux
patients with uncontrolled psychiatric disorders
active infections or malignancies
any other concomitant pathology considered as a contraindication for bariatric surgery.